OCIAD2 Antikörper (C-Term)

Produktnummer ABIN6991216

Produktdetails anti-OCIAD2 Antikörper

Target: OCIAD2 (OCIA Domain Containing 2 (OCIAD2))

Bindungsspezifität: C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser OCIAD2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF)

Aufreinigung: OCIAD2 Antibody is affinity chromatography purified via peptide column.

Immunogen: OCIAD2 antibody was raised against an 18 amino acid synthetic peptide from near the carboxy terminus of human OCIAD2. The immunogen is located within the last 50 amino acids of OCIAD2.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: OCIAD2 antibody can be used for detection of OCIAD2 by Western blot at 0.5 - 1 μ,g/mL. Antibody can also be used for immunoflourescence starting at 5 μ,g/mL. For immunofluorescence start at 5 μ,g/mL.

Antibody validated: Western Blot in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: OCIAD2 Antibody is supplied in PBS containing 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,4 °C

Informationen zur Lagerung: OCIAD2 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Details zu OCIAD2

Target: OCIAD2 (OCIA Domain Containing 2 (OCIAD2))

Andere Bezeichnung: OCIAD2 (OCIAD2 Produkte)

Synonyme: 1810027I20Rik antikoerper, OCIA domain containing 2 L homeolog antikoerper, OCIA domain containing 2 antikoerper, ociad2.L antikoerper, OCIAD2 antikoerper, Ociad2 antikoerper

Hintergrund: OCIAD2 Antibody: OCIAD2 was identified by its sequence similarity with OCIAD1, and together OCIAD1 and OCIAD2 form the OCIA domain family. OCIAD2 mRNA was found to be expressed at higher levels in invasive adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component (BAC) of the lung. Loss of OCIAD2 expression was significantly correlated with lymphatic invasion, blood vessel invasion, and lymph node metastasis, indicating that OCIAD2 may play a role in cell adhesion and prevention of cell migration. While the function of OCIAD2 is still unknown, its expression in adenocarcinoma with BAC component is significantly associated with a favorable prognosis and may serve as a marker for selecting tumors that are treatable by limited surgery.

Gen-ID: 132299

NCBI Accession: NP_001014446

UniProt: Q56VL3